DC10168Anle138b
Anle138b is an aggregation-modulating research compound studied in α-synucleinopathies. Published mouse data connect reduced oligomer burden with neuronal and motor outcomes.
View activity & prices9 research products
DC10168Anle138b is an aggregation-modulating research compound studied in α-synucleinopathies. Published mouse data connect reduced oligomer burden with neuronal and motor outcomes.
View activity & prices
DC10280BD1063 dihydrochloride is a sigma-1 receptor antagonist used to study nociplastic pain and glial responses.
View activity & prices
DC10536KML-29 is a selective MAGL inhibitor used to investigate endocannabinoid metabolism, inflammatory pain and neuropathic pain.
View activity & prices
DC10721Gefapixant (AF-219, MK-7264) is a P2X3 antagonist for ATP-gated ion-channel and sensory signaling research.
View activity & prices
DC10794PH-002 is an ApoE4 structure-correcting research compound studied in human iPSC-derived neurons with Alzheimer-related phenotypes.
View activity & prices
DC11101Soticlestat is a cholesterol 24-hydroxylase inhibitor used in cholesterol turnover and neuronal-excitability research.
View activity & prices
DC11103Tavapadon (PF-06649751) is a non-catechol D1/D5 partial agonist for dopamine-receptor and motor-function research.
View activity & prices
DC11507CLP257 is a neuronal chloride-signaling research compound originally reported as a KCC2 enhancer. Subsequent work challenged direct KCC2 activation and reported GABAA receptor potentiation.
View activity & prices
DC12396CR4056 is an imidazoline-I2 ligand for pain signaling and monoaminergic research.
View activity & pricesAnle138b is an aggregation-modulating research compound studied in α-synucleinopathies. Published mouse data connect reduced oligomer burden with neuronal and motor outcomes.

BD1063 dihydrochloride is a sigma-1 receptor antagonist used to study nociplastic pain and glial responses.

KML-29 is a selective MAGL inhibitor used to investigate endocannabinoid metabolism, inflammatory pain and neuropathic pain.

Gefapixant (AF-219, MK-7264) is a P2X3 antagonist for ATP-gated ion-channel and sensory signaling research.

PH-002 is an ApoE4 structure-correcting research compound studied in human iPSC-derived neurons with Alzheimer-related phenotypes.

Soticlestat is a cholesterol 24-hydroxylase inhibitor used in cholesterol turnover and neuronal-excitability research.

Tavapadon (PF-06649751) is a non-catechol D1/D5 partial agonist for dopamine-receptor and motor-function research.

CLP257 is a neuronal chloride-signaling research compound originally reported as a KCC2 enhancer. Subsequent work challenged direct KCC2 activation and reported GABAA receptor potentiation.

CR4056 is an imidazoline-I2 ligand for pain signaling and monoaminergic research.
